InspireMD (STU:II2) Total Current Assets: €42.03 Mil (As of Mar. 2026)

What is InspireMD Total Current Assets?

InspireMD STU:II2 43 Total Current Assets is €42.03 Mil as of Mar. 2026. GuruFocus rates STU:II2 with a GF Score™ of 43/100 and a GF Value™ of €1.55 (Possible Value Trap). The stock has 3 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. InspireMD's total current assets for the quarter that ended in Mar. 2026 was €42.03 Mil.

InspireMD (STU:II2) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

InspireMD's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	35.958	-	11.119	+	0.75 * 2.06	+	0.5 * 2.626
=	27.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD Total Current Assets Related Terms

InspireMD Total Current Assets Historical Data

* Premium members only.

The historical data trend for InspireMD's Total Current Assets can be seen below:

InspireMD Total Current Assets Chart

InspireMD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

32.83

20.13

40.49

38.70

52.50

InspireMD Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															29.73	22.08	59.97	52.50	42.03

43GF Score

InspireMD Inc STU:II2

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

InspireMD Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

InspireMD's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	46.296	+	2.193	+	2.9	+	1.107
	=	52.50

InspireMD's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	35.958	+	2.412	+	2.626	+	1.038
	=	42.03

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of €42.03 Mil mean?

InspireMD (STU:II2) has a Total Current Assets of €42.03 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for InspireMD and its competitors.

Is InspireMD's Total Current Assets too high?

InspireMD's current Total Current Assets is €42.03 Mil. Overall, InspireMD has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does InspireMD's Total Current Assets compare to TELA and BDMD?

InspireMD's Total Current Assets of €42.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Medical Devices & Instruments company?

A good Total Current Assets depends on the Medical Devices & Instruments industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for InspireMD and its competitors. InspireMD's current Total Current Assets is €42.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is InspireMD stock overvalued right now?

Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.55, compared to a current price of €0.60 — trading 61.3% below its estimated fair value. The current Total Current Assets is €42.03 Mil. InspireMD's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For InspireMD (STU:II2), the current Total Current Assets is €42.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.60 is trading 61.3% below its estimated GF Value™ of €1.55. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

Total Current Assets: €42.03 Mil
GF Value™: €1.55 vs. price of €0.60 (61.3% below fair value)
GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TELA BDMD PAVM ARAY PETV FOFA RDGL NMTC TANAF MYO ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges NSPR:USA

Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126

Website https://www.inspiremd.com

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

43GF Score

Get the complete analysis for STU:II2

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.60

Price

€1.55

GF Value

View STU:II2 Analysis

See Total Current Assets data for all stocks →